Straumann Holding AG (OTCMKTS:SAUHY) Given Consensus Recommendation of “Hold” by Brokerages

Straumann Holding AG (OTCMKTS:SAUHY) has been given an average recommendation of “Hold” by the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company.

Several brokerages have commented on SAUHY. BMO Capital Markets started coverage on Straumann in a research note on Wednesday. They set an “outperform” rating for the company. Citigroup reaffirmed a “sell” rating on shares of Straumann in a report on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Straumann in a research report on Tuesday, June 30th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. Finally, Barclays restated an “overweight” rating on shares of Straumann in a research report on Thursday, June 18th.

Straumann Stock Performance

Shares of SAUHY stock opened at $13.03 on Monday. Straumann has a twelve month low of $9.44 and a twelve month high of $14.11. The business has a fifty day simple moving average of $11.97 and a 200 day simple moving average of $11.65.

About Straumann

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.